Benzodiazepine use among adults residing in the urban settlements of Karachi, Pakistan: A cross sectional study

Substance Abuse: Treatment, Prevention, and Policy

Volumn 6, Issue 1, 2011, Pages

  Iqbal, Saleem P ^a   Ahmer, Syed ^a   Farooq, Salima ^a   Parpio, Yasmin ^a   Tharani, Ambreen ^a   Khan, Rashid A M ^a   Zaman, Mohammad ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HUMAN; MALE; MIDDLE AGED; PAKISTAN; PSYCHOLOGICAL ASPECT; RISK FACTOR; SELF MEDICATION; SOCIOECONOMICS; STATISTICS; URBAN POPULATION;

ADULT; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAKISTAN; RISK FACTORS; SELF MEDICATION; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 79960859778     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/1747-597X-6-19     Document Type: Article

References (48)

1. Balter MB, Levine J, Manheimer DI. Cross-national study of the extent of anti-anxiety-sedative drug use. N Engl J Med 1974, 290(14):769-774. 10.1056/NEJM197404042901404, 4815224.
2. Edwards C, Bushnell JL, Ashton CH, Rawlins MD. Hospital prescribing and usage of hypnotics and anxiolytics. Br J Clin Pharmacol 1991, 31(2):190-192. 1368391, 1675578.
3. Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984, 251(3):375-379. 10.1001/jama.251.3.375, 6140318.
4. Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. Br Med J (Clin Res Ed) 1988, 296(6622):601-602.
5. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med 1994, 154(11):1235-1240. 10.1001/archinte.154.11.1235, 7911297.
6. Uchibayashi M. [Leo Sternbach, an inventor of benzodiazepines]. Yakugaku Zasshi 2007, 127(1):217-224. 10.1248/yakushi.127.217, 17202803.
7. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 1994, 48(1):25-40. 10.2165/00003495-199448010-00004, 7525193.
8. de las Cuevas C, Sanz EJ. Controversial issues associated with the prescription of benzodiazepines by general practitioners and psychiatrists. Med Sci Monit 2004, 10(7):CR288-293.
9. Kapczinski F, Amaral OB, Madruga M, Quevedo J, Busnello JV, de Lima MS. Use and misuse of benzodiazepines in Brazil: a review. Subst Use Misuse 2001, 36(8):1053-1069. 10.1081/JA-100104489, 11504152.
10. Rickels K, Lucki I, Schweizer E, Garcia-Espana F, Case WG. Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation. J Clin Psychopharmacol 1999, 19(2):107-113. 10.1097/00004714-199904000-00003, 10211911.
11. Salzman C. Issues and controversies regarding benzodiazepine use. NIDA Res Monogr 1993, 131:68-88.
12. Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed) 1981, 283(6292):643-645.
13. Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1981, 1(8219):520-522.
14. Lader M. Benzodiazepine dependence. Prog Neuropsychopharmacol Biol Psychiatry 1984, 8(1):85-95. 10.1016/0278-5846(84)90139-8, 6145190.
15. Khan MM, Reza H. Benzodiazepine self-poisoning in Pakistan: implications for prevention and harm reduction. J Pak Med Assoc 1998, 48(10):293-295.
16. Khawaja MR, Majeed A, Malik F, Merchant KA, Maqsood M, Malik R, Mazahir S, Naqvi H. Prescription pattern of benzodiazepines for inpatients at a tertiary care university hospital in Pakistan. J Pak Med Assoc 2005, 55(6):259-263.
17. Bonsack C, Camus D, Kaufmann N, Aubert AC, Besson J, Baumann P, Borgeat F, Gillet M, Eap CB. Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening. Addict Behav 2006, 31(7):1252-1258. 10.1016/j.addbeh.2005.08.008, 16137835.
18. Zandstra SM, Furer JW, van de Lisdonk EH, van't HM, Bor JH, van Weel C, Zitman FG. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002, 37(3):139-144. 10.1007/s001270200006, 11990011.
19. Substance Abuse and Mental Health Services Administration Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4856 Findings). Rockville, MD 2010, Substance Abuse and Mental Health Services Administration.
20. Ahmer S, Salamat S, Khan RA, Iqbal SP, Haider II, Khan AS, Zafar M. Pattern of benzodiazepine use in psychiatric outpatients in Pakistan: a cross-sectional survey. Clin Pract Epidemiol Ment Health 2009, 5:9. 10.1186/1745-0179-5-9, 2683813, 19400933.
21. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001, 57(5):419-425. 10.1007/s002280100326, 11599660.
22. Gleason PP, Schulz R, Smith NL, Newsom JT, Kroboth PD, Kroboth FJ, Psaty BM. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998, 13(4):243-250. 10.1046/j.1525-1497.1998.00074.x, 1496936, 9565387.
23. Mayer-Oakes SA, Kelman G, Beers MH, De Jong F, Matthias R, Atchison KA, Lubben JE, Schweitzer SO. Benzodiazepine use in older, community-dwelling southern Californians: prevalence and clinical correlates. Ann Pharmacother 1993, 27(4):416-421.
24. Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambui Health and Aging Study (BHAS). Rev Bras Psiquiatr 2008, 30(1):7-11. 10.1590/S1516-44462006005000062, 17992360.
25. Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E. A population based study on health conditions associated with the use of benzodiazepines among older adults (The Bambui Health and Aging Study). Cad Saude Publica 2009, 25(3):605-612. 10.1590/S0102-311X2009000300015, 19300849.
26. Hall SA, Chiu GR, Kaufman DW, Kelly JP, Link CL, Kupelian V, McKinlay JB. General exposures to prescription medications by race/ethnicity in a population-based sample: results from the Boston Area Community Health Survey. Pharmacoepidemiol Drug Saf 2010, 19(4):384-392.
27. Lagnaoui R, Depont F, Fourrier A, Abouelfath A, Begaud B, Verdoux H, Moore N. Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol 2004, 60(7):523-529. 10.1007/s00228-004-0808-2, 15338086.
28. Naja WJ, Pelissolo A, Haddad RS, Baddoura R, Baddoura C. A general population survey on patterns of benzodiazepine use and dependence in Lebanon. Acta Psychiatr Scand 2000, 102(6):429-431. 10.1034/j.1600-0447.2000.102006429.x, 11142431.
29. Demyttenaere K, Bonnewyn A, Bruffaerts R, De Girolamo G, Gasquet I, Kovess V, Haro JM, Alonso J. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disord 2008, 110(1-2):84-93. 10.1016/j.jad.2008.01.011, 18329721.
30. Schmidt LG, Grohmann R, Muller-Oerlinghausen B, Otto M, Ruther E, Wolf B. Prevalence of benzodiazepine abuse and dependence in psychiatric in-patients with different nosology. An assessment of hospital-based drug surveillance data. Br J Psychiatry 1989, 154:839-843. 10.1192/bjp.154.6.839, 2574611.
31. Taylor D, Paton C, Kerwin R. The Maudsly 2005-2006 Prescribing Guidelines 2005, Taylor & Francis. London, 8.
32. Sonnenberg CM, Bierman EJ, Deeg DJ, Comijs HC, van Tilburg W, Beekman AT. Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatry Psychiatr Epidemiol 2011,
33. Petitjean S, Ladewig D, Meier CR, Amrein R, Wiesbeck GA. Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. Int Clin Psychopharmacol 2007, 22(5):292-298. 10.1097/YIC.0b013e328105e0f2, 17690598.
34. Lyndon RW, Russell JD. Benzodiazepine use in a rural general practice population. Aust N Z J Psychiatry 1988, 22(3):293-298. 10.3109/00048678809161210, 2902838.
35. Magrini N, Vaccheri A, Parma E, D'Alessandro R, Bottoni A, Occhionero M, Montanaro N. Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol 1996, 50(1-2):19-25. 10.1007/s002280050063, 8739806.
36. Swartz M, Landerman R, George LK, Melville ML, Blazer D, Smith K. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. Am J Public Health 1991, 81(5):592-596. 10.2105/AJPH.81.5.592, 1405082, 1673048.
37. Fernandez L, Cassagne-Pinel C. [Benzodiazepine addiction and symptoms of anxiety and depression in elderly subjects]. Encephale 2001, 27(5):459-474.
38. Llorente MD, David D, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatry Neurol 2000, 13(3):150-160.
39. Chassin MR, Brook RH, Park RE, Keesey J, Fink A, Kosecoff J, Kahn K, Merrick N, Solomon DH. Variations in the use of medical and surgical services by the Medicare population. N Engl J Med 1986, 314(5):285-290. 10.1056/NEJM198601303140505, 3510394.
40. Voyer P, Cohen D, Lauzon S, Collin J. Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies. BMC Nurs 2004, 3(1):3. 10.1186/1472-6955-3-3, 514897, 15310409.
41. Jorm AF, Grayson D, Creasey H, Waite L, Broe GA. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 2000, 24(1):7-10. 10.1111/j.1467-842X.2000.tb00715.x, 10777971.
42. Huf G, Lopes C, Rozenfeld S. [Long-term benzodiazepine use in women at a daycare center for older people]. Cad Saude Publica 2000, 16(2):351-362. 10.1590/S0102-311X2000000200006, 10883034.
43. American Psychiatric Association Benzodiazepine dependence, toxicity and abuse. A task force report of the American Psychiatric Association 1990, Washington, D.C. American Psychiatric Association, American Psychiatric Association.
44. Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull 1998, 34(2):139-153.
45. Salzman C. The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. Am J Psychiatry 1991, 148(2):151-152.
46. Cook PJ. Benzodiazepine hypnotics in the elderly. Acta Psychiatr Scand Suppl 1986, 332:149-158.
47. Petrovic M, Mariman A, Warie H, Afschrift M, Pevernagie D. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 2003, 58(1):27-36.
48. Esposito E, Barbui C, Patten SB. Patterns of benzodiazepine use in a Canadian population sample. Epidemiol Psichiatr Soc 2009, 18(3):248-254.